Drug Type Small molecule drug |
Synonyms HY 22017, HY-22017, HY22017 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Duodenal Ulcer | NDA/BLA | CN | 19 Feb 2024 | |
Gastro-Enteropancreatic Neuroendocrine Tumor | IND Approval | CN | 17 Jul 2023 |